SCHEMBL23861570

SCHEMBL23861570

Oc1cc(C(c2ccccc2)(c2ccccc2)c2cc(O)c3cccc(O)c3c2)cc2c(O)cccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.44
▸ CYP1A2 P05177 2/20 0.43
▸ TRPM4 Q8TD43 1/20 0.41
▸ CDK2 P24941 1/20 0.40
▸ THRB P10828 2/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ APP P05067 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ SNCA P37840 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861542 0.81 ESR1 (0.51) IDO1CYP1A2TRPM4CDK2THRB
SCHEMBL23861355 0.77 ESR1 (0.39) CYP1A2CDK2HDAC4HDAC2HDAC8
SCHEMBL1314866 0.77 IDO1 (0.60) IDO1CYP1A2TRPM4CDK2THRB
SCHEMBL23861626 0.74 THRB (0.44) IDO1CYP1A2TRPM4THRBHSD17B10
SCHEMBL23861571 0.74 HSD17B10 (0.45) IDO1CYP1A2CDK2THRBHSD17B10
SCHEMBL23861573 0.73 THRB (0.47) IDO1CYP1A2TRPM4THRBHSD17B10
SCHEMBL23861568 0.73 ESR1 (0.46) IDO1CYP1A2TRPM4CDK2THRB
SCHEMBL18308670 0.72 IDO1 (0.54) IDO1CYP1A2THRBHSD17B10MAPT
SCHEMBL1618019 0.71 ALDH1A1 (0.58) HSD17B10MAPTALOX15HPGDAPP
SCHEMBL9973589 0.71 ALDH1A1 (0.58) HSD17B10MAPTALOX15HPGDAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 IDO1 3632/4885CYP1A2 2085/4885TRPM4 4031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback